check_circleStudy Completed

Erectile Dysfunction

BAY38-7268, ODT formulation finding, 10 mg SD

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

18 - 50 Years
  • -

  • -

Trial summary

Enrollment Goal
15
Trial Dates
November 2004 - December 2004
Phase
Phase 1
Could I Receive a placebo
N/A
Products
Vardenafil ODT (BAY38-9456)
Accepts Healthy Volunteer
N/A

Where to participate

StatusInstitutionLocation
Completed
MEDA Manufacturing GmbH, ClinPharmCologneKöln, 51063, Germany

Trial design

Randomized, three-fold crossover single-dose study to investigate the relative bioavailability of two respective 10 mg vardenafil oral disintegrating tablet formulations in comparison to a 10 mg standard tablet in 12 healthy male subjects
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A